Scinai Immunotherapeutics Ltd. (SCNI)
1.72
+0.02
(+1.18%)
USD |
NASDAQ |
Sep 09, 16:00
1.72
0.00 (0.00%)
After-Hours: 19:05
Scinai Immunotherapeutics Total Liabilities (Quarterly) : 5.443M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.443M |
| March 31, 2026 | 5.827M |
| December 31, 2025 | 3.523M |
| September 30, 2025 | |
| June 30, 2025 | 3.982M |
| March 31, 2025 | |
| December 31, 2024 | 3.471M |
| September 30, 2024 | 2.258M |
| June 30, 2024 | 22.14M |
| March 31, 2024 | 22.17M |
| December 31, 2023 | 22.04M |
| September 30, 2023 | 21.27M |
| June 30, 2023 | 27.01M |
| March 31, 2023 | 28.10M |
| December 31, 2022 | |
| September 30, 2022 | 18.37M |
| June 30, 2022 | 23.16M |
| March 31, 2022 | 24.87M |
| December 31, 2021 | 24.50M |
| September 30, 2021 | 23.82M |
| June 30, 2021 | 23.53M |
| March 31, 2021 | 22.17M |
| December 31, 2020 | 22.27M |
| September 30, 2020 | 22.44M |
| June 30, 2020 | 38.99M |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | 48.06M |
| September 30, 2019 | 36.05M |
| June 30, 2019 | 37.48M |
| March 31, 2019 | 31.79M |
| December 31, 2018 | 32.76M |
| September 30, 2018 | 14.66M |
| June 30, 2018 | 8.569M |
| March 31, 2018 | 5.323M |
| December 31, 2017 | 4.362M |
| September 30, 2017 | 4.259M |
| June 30, 2017 | 5.778M |
| March 31, 2017 | 3.361M |
| December 31, 2016 | 1.168M |
| September 30, 2016 | 1.211M |
| June 30, 2016 | 1.597M |
| March 31, 2016 | 1.644M |
| December 31, 2015 | 1.995M |
| September 30, 2015 | 2.104M |
| June 30, 2015 | 2.515M |
| March 31, 2015 | 0.427M |
| December 31, 2014 | 0.4818M |
| September 30, 2014 | 0.4112M |
| June 30, 2014 | 0.4751M |
| March 31, 2014 | 0.4882M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd. | 49.63M |
| Pluri, Inc. | 39.06M |
| Evogene Ltd. | 4.542M |
| CollPlant Biotechnologies Ltd. | 4.297M |
| Regentis Biomaterials Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.17M |
| Shareholders Equity (Quarterly) | 11.73M |
| Debt to Equity Ratio | 0.3052 |
| Current Ratio | 1.563 |
| Net Debt Paydown Yield | -49.73% |